Global Fallopian Tube Cancer Therapeutics Market 2024-2028

Global Fallopian Tube Cancer Therapeutics Market 2024-2028


The fallopian tube cancer therapeutics market is forecasted to grow by USD 832.01 mn during 2023-2028, accelerating at a CAGR of 10.35% during the forecast period. The report on the fallopian tube cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing attention toward women's health, the array of strong drug approvals, and rising awareness of gynecological cancers.

Technavio's fallopian tube cancer therapeutics market is segmented as below:

By End-user
  • Hospitals
  • Clinics and ASCs
  • Others
By Product
  • Targeted therapy
  • Chemotherapy
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing research on regenerative therapies as one of the prime reasons driving the fallopian tube cancer therapeutics market growth during the next few years. Also, advent of treatment vaccines for cancer and growing usage of nanotechnology for effective treatment will lead to sizable demand in the market.

The report on the fallopian tube cancer therapeutics market covers the following areas:
  • Fallopian tube cancer therapeutics market sizing
  • Fallopian tube cancer therapeutics market forecast
  • Fallopian tube cancer therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading fallopian tube cancer therapeutics market vendors that include AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC, AstraZeneca Plc, Baxter International Inc., BioVaxys Technology Corp., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Clinigen Group Plc, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, ImmunoGen Inc., Johnson and Johnson, Merck and Co. Inc., Novartis AG, Pfizer Inc., Siemens Healthineers AG, Sun Pharmaceutical Industries Ltd., and Clovis Oncology Inc.. Also, the fallopian tube cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth


  • Executive Summary
    • Market overview
      • Table Executive Summary – Chart on Market Overview
      • Table Executive Summary – Data Table on Market Overview
      • Table Executive Summary – Chart on Global Market Characteristics
      • Table Executive Summary – Chart on Market by Geography
      • Table Executive Summary – Chart on Market Segmentation by End-user
      • Table Executive Summary – Chart on Market Segmentation by Product
      • Table Executive Summary – Chart on Incremental Growth
      • Table Executive Summary – Data Table on Incremental Growth
      • Table Executive Summary – Chart on Vendor Market Positioning
  • Market Landscape
    • Market ecosystem
      • Table Parent market
      • Table Market Characteristics
  • Market Sizing
    • Market definition
      • Table Offerings of vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2023
    • Market outlook: Forecast for 2023-2028
      • Table Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Table Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Historic Market Size
    • Global fallopian tube cancer therapeutics market 2018 - 2022
      • Table Historic Market Size – Data Table on global fallopian tube cancer therapeutics market 2018 - 2022 ($ million)
    • End-user Segment Analysis 2018 - 2022
      • Table Historic Market Size – End-user Segment 2018 - 2022 ($ million)
    • Product Segment Analysis 2018 - 2022
      • Table Historic Market Size – Product Segment 2018 - 2022 ($ million)
    • Geography Segment Analysis 2018 - 2022
      • Table Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • Country Segment Analysis 2018 - 2022
      • Table Historic Market Size – Country Segment 2018 - 2022 ($ million)
  • Five Forces Analysis
    • Five forces summary
      • Table Five forces analysis - Comparison between 2023 and 2028
    • Bargaining power of buyers
      • Table Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • Threat of new entrants
      • Table Threat of new entrants – Impact of key factors in 2023 and 2028
    • Threat of substitutes
      • Table Threat of substitutes – Impact of key factors in 2023 and 2028
    • Threat of rivalry
      • Table Threat of rivalry – Impact of key factors in 2023 and 2028
    • Market condition
      • Table Chart on Market condition - Five forces 2023 and 2028
  • Market Segmentation by End-user
    • Market segments
      • Table Chart on End-user - Market share 2023-2028 (%)
      • Table Data Table on End-user - Market share 2023-2028 (%)
    • Comparison by End-user
      • Table Chart on Comparison by End-user
      • Table Data Table on Comparison by End-user
    • Hospitals - Market size and forecast 2023-2028
      • Table Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Hospitals - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
    • Clinics and ASCs - Market size and forecast 2023-2028
      • Table Chart on Clinics and ASCs - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Clinics and ASCs - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Clinics and ASCs - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Clinics and ASCs - Year-over-year growth 2023-2028 (%)
    • Others - Market size and forecast 2023-2028
      • Table Chart on Others - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Others - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Others - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Others - Year-over-year growth 2023-2028 (%)
    • Market opportunity by End-user
      • Table Market opportunity by End-user ($ million)
      • Table Data Table on Market opportunity by End-user ($ million)
  • Market Segmentation by Product
    • Market segments
      • Table Chart on Product - Market share 2023-2028 (%)
      • Table Data Table on Product - Market share 2023-2028 (%)
    • Comparison by Product
      • Table Chart on Comparison by Product
      • Table Data Table on Comparison by Product
    • Targeted therapy - Market size and forecast 2023-2028
      • Table Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
    • Chemotherapy - Market size and forecast 2023-2028
      • Table Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
    • Market opportunity by Product
      • Table Market opportunity by Product ($ million)
      • Table Data Table on Market opportunity by Product ($ million)
  • Customer Landscape
    • Customer landscape overview
      • Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Geographic Landscape
    • Geographic segmentation
      • Table Chart on Market share by geography 2023-2028 (%)
      • Table Data Table on Market share by geography 2023-2028 (%)
    • Geographic comparison
      • Table Chart on Geographic comparison
      • Table Data Table on Geographic comparison
    • North America - Market size and forecast 2023-2028
      • Table Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Table Chart on North America - Year-over-year growth 2023-2028 (%)
      • Table Data Table on North America - Year-over-year growth 2023-2028 (%)
    • Europe - Market size and forecast 2023-2028
      • Table Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • Asia - Market size and forecast 2023-2028
      • Table Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • Rest of World (ROW) - Market size and forecast 2023- 2028
      • Table Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • US - Market size and forecast 2023-2028
      • Table Chart on US - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Table Chart on US - Year-over-year growth 2023-2028 (%)
      • Table Data Table on US - Year-over-year growth 2023-2028 (%)
    • Germany - Market size and forecast 2023-2028
      • Table Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • China - Market size and forecast 2023-2028
      • Table Chart on China - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Table Chart on China - Year-over-year growth 2023-2028 (%)
      • Table Data Table on China - Year-over-year growth 2023-2028 (%)
    • Canada - Market size and forecast 2023-2028
      • Table Chart on Canada - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Canada - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • UK - Market size and forecast 2023-2028
      • Table Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Table Chart on UK - Year-over-year growth 2023-2028 (%)
      • Table Data Table on UK - Year-over-year growth 2023-2028 (%)
    • Market opportunity by geography
      • Table Market opportunity by geography ($ million)
      • Table Data Tables on Market opportunity by geography ($ million)
  • Drivers, Challenges, and Trends
    • Market drivers
      • Growing attention toward women health
      • Array of strong drug approvals
      • Rising awareness of gynecological cancers
    • Market challenges
      • Difficulty in diagnosis of fallopian tube cancer
      • Strong threat from substitutes for fallopian tube cancer therapeutics
      • High cost of treatment of fallopian tube cancer
    • Impact of drivers and challenges
      • Table Impact of drivers and challenges in 2023 and 2028
    • Market trends
      • Growing research on regenerative therapies
      • Advent of treatment vaccines for cancer
      • Growing usage of nanotechnology for effective treatment
  • Vendor Landscape
    • Overview
    • Vendor landscape
      • Table Overview on Criticality of inputs and Factors of differentiation
    • Landscape disruption
      • Table Overview on factors of disruption
    • Industry risks
      • Table Impact of key risks on business
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Matrix on vendor position and classification
    • AbbVie Inc.
      • Table AbbVie Inc. - Overview
      • Table AbbVie Inc. - Product / Service
      • Table AbbVie Inc. - Key news
      • Table AbbVie Inc. - Key offerings
    • Amgen Inc.
      • Table Amgen Inc. - Overview
      • Table Amgen Inc. - Product / Service
      • Table Amgen Inc. - Key offerings
    • AstraZeneca Plc
      • Table AstraZeneca Plc - Overview
      • Table AstraZeneca Plc - Product / Service
      • Table AstraZeneca Plc - Key news
      • Table AstraZeneca Plc - Key offerings
    • Baxter International Inc.
      • Table Baxter International Inc. - Overview
      • Table Baxter International Inc. - Business segments
      • Table Baxter International Inc. - Key news
      • Table Baxter International Inc. - Key offerings
      • Table Baxter International Inc. - Segment focus
    • Boehringer Ingelheim International GmbH
      • Table Boehringer Ingelheim International GmbH - Overview
      • Table Boehringer Ingelheim International GmbH - Business segments
      • Table Boehringer Ingelheim International GmbH - Key news
      • Table Boehringer Ingelheim International GmbH - Key offerings
      • Table Boehringer Ingelheim International GmbH - Segment focus
    • Bristol Myers Squibb Co.
      • Table Bristol Myers Squibb Co. - Overview
      • Table Bristol Myers Squibb Co. - Product / Service
      • Table Bristol Myers Squibb Co. - Key news
      • Table Bristol Myers Squibb Co. - Key offerings
    • Clovis Oncology Inc.
      • Table Clovis Oncology Inc. - Overview
      • Table Clovis Oncology Inc. - Product / Service
      • Table Clovis Oncology Inc. - Key offerings
    • Eli Lilly and Co.
      • Table Eli Lilly and Co. - Overview
      • Table Eli Lilly and Co. - Product / Service
      • Table Eli Lilly and Co. - Key news
      • Table Eli Lilly and Co. - Key offerings
    • F. Hoffmann La Roche Ltd.
      • Table F. Hoffmann La Roche Ltd. - Overview
      • Table F. Hoffmann La Roche Ltd. - Business segments
      • Table F. Hoffmann La Roche Ltd. - Key news
      • Table F. Hoffmann La Roche Ltd. - Key offerings
      • Table F. Hoffmann La Roche Ltd. - Segment focus
    • GlaxoSmithKline Plc
      • Table GlaxoSmithKline Plc - Overview
      • Table GlaxoSmithKline Plc - Business segments
      • Table GlaxoSmithKline Plc - Key news
      • Table GlaxoSmithKline Plc - Key offerings
      • Table GlaxoSmithKline Plc - Segment focus
    • ImmunoGen Inc.
      • Table ImmunoGen Inc. - Overview
      • Table ImmunoGen Inc. - Product / Service
      • Table ImmunoGen Inc. - Key offerings
    • Johnson and Johnson
      • Table Johnson and Johnson - Overview
      • Table Johnson and Johnson - Business segments
      • Table Johnson and Johnson - Key news
      • Table Johnson and Johnson - Key offerings
      • Table Johnson and Johnson - Segment focus
    • Merck and Co. Inc.
      • Table Merck and Co. Inc. - Overview
      • Table Merck and Co. Inc. - Business segments
      • Table Merck and Co. Inc. - Key news
      • Table Merck and Co. Inc. - Key offerings
      • Table Merck and Co. Inc. - Segment focus
    • Novartis AG
      • Table Novartis AG - Overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Segment focus
    • Pfizer Inc.
      • Table Pfizer Inc. - Overview
      • Table Pfizer Inc. - Product / Service
      • Table Pfizer Inc. - Key news
      • Table Pfizer Inc. - Key offerings
  • Appendix
    • Scope of the report
      • Market definition
      • Objectives
      • Notes and caveats
    • Inclusions and exclusions checklist
      • Table Inclusions checklist
      • Table Exclusions checklist
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings